Event-Driven Stocks

America Great Health

Healthcare · Pharmaceutical Preparations · CA · SEC filings ↗ · Compare ⊕

Signs2 good4 warning3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$391,743$294,670$204,308$104,648$195,671$5,474
Operating income−$382,935−$782,700−$492,644−$4.7M−$243,560−$46,151
Net income−$719,119−$1.2M−$761,420−$4.9M−$269,054−$51,916
Total assets$301,817$323,478$299,129$336,143$623,018$3,894
Total liabilities$6.0M$5.4M$4.7M$4.2M$1.1M$218,901
Equity−$5.7M−$5.0M−$4.3M−$3.8M−$467,827−$215,007
EPS (diluted)$0.00$0.00$0.00
Shares out.21.15B21.19B21.11B21.09B21.08B20.24B

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−97.8%
Net margin
−183.6%
Return on equity
12.7%
Return on assets
−238.3%
Return on capital (ROCE)
Liabilities / assets
2003.1%
Debt / equity
Book value / share
$-0.00
Revenue growth (YoY)
32.9%
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-203.86distress
Accruals / assets
128.0%clean
Beneish M-Score
-9.40normal
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
45
/ 100
Profitability 25Growth 100Catalyst 33Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 severe4 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • Operating losses (negative operating margin)
  • Reported a net loss
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Revenue is growing year-over-year
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (1)